✦ LIBER ✦

Role of botulinum toxin in migraine therapy

✍ Scribed by Wilhelm J. Schulte-Mattler; Elke Leinisch

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 118 KB
Volume: 68
Category: Article
ISSN: 0272-4391
DOI: 10.1002/ddr.20206

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Botulinum toxin antibody type A titres a

Botulinum toxin antibody type A titres after cessation of botulinum toxin therapy

✍ Dirk Dressler; Hans Bigalke 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

## Abstract In some patients, therapy with botulinum toxin type A (BT‐A) becomes ineffective due to formation of antibodies (BT‐A‐AB). The time course of BT‐A‐AB titres after cessation of BT‐A therapy was quantitatively studied to determine whether and when they might drop. Thirteen patients (eight

Basic immunological aspects of botulinum

Basic immunological aspects of botulinum toxin therapy

✍ M. Zouhair Atassi 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 282 KB

Previous studies in this laboratory had mapped the immune recognition profile of the regions recognized antibodies (Abs) and by T cells on the protective H C domain (Cterminal fragment corresponding to residues 855-1296 of the heavy chain) of botulinum neurotoxin serotype A (BoNT/A). The localizatio

Moving ear syndrome: The role of botulin

Moving ear syndrome: The role of botulinum toxin

✍ Clecio Godeiro-Junior; Andre Carvalho Felicio; Evandro Penteado Villar Felix; Gi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

## Abstract We report a 30‐year‐old man with moving ear syndrome caused by focal myoclonic jerks of the right temporal muscle. This focal myoclonus would disappear while the patient was sleeping, swallowing, or speaking. He was treated with botulinum toxin type A with a favorable outcome. Previous

Dynamic balance function in phasic cervi

Dynamic balance function in phasic cervical dystonia following Botulinum toxin therapy

✍ Jörg Müller; Georg Ebersbach; Jörg Wissel; Werner Poewe 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB

## Abstract Previous research by our group revealed normal dynamic balance function in pure tonic cervical dystonia (CD) with impaired equilibrium in phasic CD patients investigated at least 3 months following Botulinum toxin (BtxA) treatment. The current study was performed to determine whether im

Different types of botulinum toxin in hu

Different types of botulinum toxin in humans

✍ Roberto Eleopra; Valeria Tugnoli; Rocco Quatrale; Ornella Rossetto; Cesare Monte 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

In humans, botulinum neurotoxin (BoNT) serotype A (BoNT/A) is a useful therapeutic tool, but different BoNT serotypes may be useful when a specific immune resistance related to BoNT/A is proved. BoNT serotype F (BoNT/F) was injected into human muscles but its effects are shorter compared to BoNT/A,

Physiological effects of botulinum toxin

Physiological effects of botulinum toxin in spasticity

✍ Jean-Michel Gracies 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

There is considerable evidence that injection of botulinum toxin (BTX) into muscles with spastic overactivity reduces resistance to passive movement in joints supplied by the injected muscles. The demonstration of improvement in active performance of the paretic limbs has been only anecdotal to date